Le Lézard
Classified in: Health, Science and technology

Waystar Expands Leadership Team to Accelerate Growth and Advancement Within Health Systems and Hospitals


LOUISVILLE, Ky. and CHICAGO and ATLANTA and BOSTON, Nov. 14, 2018 /PRNewswire/ -- Waystar, a top-rated revenue cycle technology company, today announced four new additions to its executive leadership team. Tad Kendall joins the company as chief sales officer, Jeff Hurst as EVP of the client success team, Peter J. Siavelis as SVP of health systems and hospitals and Tracey Weinberg as SVP of marketing. The new leadership will add to Waystar's seasoned team of healthcare, tech and finance industry veterans, who have grown the company into a revenue cycle management leader whose next-generation platform is used by more than 450,000 providers, 22,000 healthcare organizations and 750 health systems and hospitals.

"As we move toward our next phase of growth and success, it is essential that we have the right leadership in place. The combined knowledge of our new executives positions us well to become even more of a market leader," said Matt Hawkins, CEO of Waystar. "We are thrilled to have them join our team as we work toward our commitment to drastically improving the revenue cycle for hospitals and health systems."

Tad Kendall, chief sales officer, will lead overall sales strategy and activity. A go-to-market leader with more than 25 years of experience in the healthcare and life sciences industries, Kendall has a proven track record of building and leading a high-performance sales culture across large organizations, generating quality growth and creating a differentiated client experience. He most recently served as SVP of go-to-market for Cotiviti where he led growth from $300 million in sales to $700 million, playing a major role in its IPO and $4.9 billion private equity acquisition.

Hurst will head up the client success team as EVP. A seasoned executive, he brings more than 20 years of leadership experience in both the hospital and technology spaces. He most recently served as SVP of revenue cycle management and president of RevWorks at Cerner, where he helped grow revenue by more than $250 million in just two years. Before joining Cerner, Jeff was SVP and senior finance officer at Florida Hospital (of Adventist Health System), where he oversaw the single-largest IT implementation in the hospital's history.

Peter J. Siavelis, SVP of health systems and hospitals, will be responsible for managing the growth of this important segment, overseeing strategy development and refining Waystar's platform solutions. Siavelis is an accomplished sales strategist with more than 20 years of experience in healthcare IT, medical informatics and sales management at a number of prominent healthcare technology businesses. He was previously CCO at StayWell and has served as president of Merge Healthcare's U.S. sales.

Tracey Weinberg, SVP of marketing, will drive the marketing team to elevate the Waystar brand in support of company growth. With deep expertise in customer acquisition, brand development and public relations, Weinberg has spearheaded marketing at several disruptive technology and fintech companies during periods of rapid expansion, resulting in acquisition by Fortune 500 companies. Prior to joining Waystar, Weinberg held marketing leadership roles at Braintree (acquired by PayPal), iPay Technologies (acquired by Jack Henry & Associates) and Orbitz.

Kendall, Hurst, Siavelis and Weinberg join Waystar during a period of transformative growth.  The company recently acquired the transaction services arm of Ovation, a patient verification and claims status solution vendor, as well as predictive analytics and workflow solutions company Connance. These new executives bring vital expertise that will guide Waystar as it advances its capabilities for health systems and hospitals and continues to reshape the revenue cycle.

About Waystar:
Waystar is a leading provider of technology solutions that simplify the healthcare revenue cycle to improve the financial health of their clients. Waystar's innovative technology allows clients to collect more with less cost and less stress, so they can focus on their goals, patients and communities. Waystar has scored Best in KLAS® claims clearinghouse every year since 2010, including 2018, and earned multiple #1 rankings in both medical claims processing and patient payment solutions from Black Booktm surveys since 2012. The Waystar platform supports more than 450,000 providers, hospitals, health systems and ambulatory services organizations and partners with the leading EHR and practice management solution providers. For more information, visit waystar.com, or follow @Waystar, on Twitter.

CONTACT: Quincy Zhai, 917-789-0218, [email protected]

SOURCE Waystar


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: